Approval · Notice of Compliance 8104 · 2006
INFANRIX: Notice of Compliance 8104
Issued June 30, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8104
- Date
- June 30, 2006
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFANRIX | Not yet assigned | — |
Medicinal ingredients
- PERTUSSIS TOXOID 25 MCG per 0.5ML
- FILAMENTOUS HAEMAGGLUTININ 25 MCG per 0.5ML
- PERTACTIN 8 MCG per 0.5ML
- TETANUS TOXOID ADSORBED 10 LF per 0.5ML
- DIPHTHERIA TOXOID ADSORBED 25 LF per 0.5ML